$54.97
3.48% yesterday
NYSE, Jun 12, 10:10 pm CET
ISIN
US2074101013
Symbol
CNMD

Conmed Corp. Stock price

$54.97
-5.76 9.48% 1M
-17.69 24.35% 6M
-13.47 19.68% YTD
-18.28 24.96% 1Y
-15.42 21.91% 5Y
-1.25 2.22% 10Y
+24.15 78.36% 20Y
NYSE, Closing price Thu, Jun 12 2025
-1.98 3.48%
ISIN
US2074101013
Symbol
CNMD
Sector

Key metrics

Market capitalization $1.70b
Enterprise Value $2.56b
P/E (TTM) P/E ratio 14.39
EV/FCF (TTM) EV/FCF 15.54
EV/Sales (TTM) EV/Sales 1.94
P/S ratio (TTM) P/S ratio 1.29
P/B ratio (TTM) P/B ratio 1.74
Dividend yield 1.46%
Last dividend (FY24) $0.80
Revenue growth (TTM) Revenue growth 4.31%
Revenue (TTM) Revenue $1.32b
EBIT (operating result TTM) EBIT $191.88m
Free Cash Flow (TTM) Free Cash Flow $164.55m
Cash position $35.49m
EPS (TTM) EPS $3.82
P/E forward 14.13
P/S forward 1.25
EV/Sales forward 1.88
Short interest 11.53%
Show more

Is Conmed Corp. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,845 stocks worldwide.

Conmed Corp. Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Conmed Corp. forecast:

1x Buy
17%
5x Hold
83%

Analyst Opinions

6 Analysts have issued a Conmed Corp. forecast:

Buy
17%
Hold
83%

Financial data from Conmed Corp.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,316 1,316
4% 4%
100%
- Direct Costs 577 577
1% 1%
44%
739 739
7% 7%
56%
- Selling and Administrative Expenses 469 469
2% 2%
36%
- Research and Development Expense 54 54
0% 0%
4%
227 227
23% 23%
17%
- Depreciation and Amortization 35 35
1% 1%
3%
EBIT (Operating Income) EBIT 192 192
28% 28%
15%
Net Profit 119 119
44% 44%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Conmed Corp. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Conmed Corp. Stock News

Neutral
Business Wire
23 days ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that LaVerne Council has been appointed to succeed Martha Goldberg Aronson as the new Independent Chair of its Board of Directors, effective May 21, 2025. “LaVerne's extensive experience as a global operations and information technology executive have been invaluable to CONMED, and I know that her experience will cont...
Neutral
Business Wire
23 days ago
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 20, 2025, payable on July 3, 2025, to all shareholders of record as of June 13, 2025. About CONMED Corporation CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company's produ...
Neutral
Seeking Alpha
about one month ago
CONMED Corporation (NYSE:CNMD ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Pat Beyer - Chief Executive Officer and President Todd Garner - Executive Vice President and Chief Financial Officer Conference Call Participants Matt O'Brien - Piper Sandler Robbie Marcus - JPMorgan Rick Wise - Stifel Young Li - Jefferies Travis Steed - Bank of America Mike Matson - ...
More Conmed Corp. News

Company Profile

CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its products are used by surgeons and physicians in a variety of medical specialties, including orthopedic surgery, general surgery, gynecology, neurosurgery, thoracic surgery and gastroenterology. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Head office United States
CEO Patrick Beyer
Employees 3,900
Founded 1970
Website www.conmed.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today